BCAB (STOCKS)
BioAtla, Inc. Common Stock
$3.799900
+0.249900 (+7.04%)
Prev close: $3.550000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jay M. Short
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $6.11M
- Employees
- 61
- P/E (TTM)
- -0.09
- P/B (TTM)
- -0.16
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-8.00 | $-12.24 | +4.2400 | +34.64% |
|
Sep 2025 (Q3)
|
$-13.50 | $-15.13 | +1.6302 | +10.77% |
|
Jun 2025 (Q2)
|
$-16.00 | $-17.21 | +1.2125 | +7.04% |
|
Mar 2025 (Q1)
|
$-13.00 | $-17.68 | +4.6802 | +26.47% |
Financial Statements
| Revenues | $2.00M |
| Operating Expenses | $53.00M |
| Research and Development | $35.80M |
| Other Operating Expenses | $17.20M |
| Operating Income/Loss | -$51.00M |
| Income/Loss From Continuing Operations After Tax | -$50.62M |
| Income/Loss From Continuing Operations Before Tax | -$50.62M |
| Net Income/Loss | -$50.62M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$50.62M |
| Net Income/Loss Available To Common Stockholders, Basic | -$50.62M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.97 |
| Diluted Earnings Per Share | -$4.97 |
| Basic Average Shares | 119,077,850 |
| Diluted Average Shares | 119,077,850 |
| Assets | $8.57M |
| Current Assets | $3.09M |
| Noncurrent Assets | $5.47M |
| Fixed Assets | $0.00 |
| Liabilities | $45.88M |
| Current Liabilities | $20.69M |
| Accounts Payable | $12.12M |
| Other Current Liabilities | $8.57M |
| Noncurrent Liabilities | $25.18M |
| Equity | -$37.31M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$37.31M |
| Liabilities And Equity | $8.57M |
| Net Cash Flow From Operating Activities | -$37.18M |
| Net Cash Flow From Operating Activities, Continuing | -$37.18M |
| Net Cash Flow From Investing Activities | $30.40M |
| Net Cash Flow From Investing Activities, Continuing | $30.40M |
| Net Cash Flow From Financing Activities | $6.78M |
| Net Cash Flow From Financing Activities, Continuing | $6.78M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$50.62M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$50.62M |
| Other Comprehensive Income/Loss | $0.00 |